MS

Maddi Shanthi

Active Director Director DIN 10390276
DIN 10390276 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Maddi Shanthi

Data last updated:

Maddi Shanthi is a Director at Calian Molecules Private Limited (since 2023). The company operates in Paper. Calian Molecules Private Limited reported revenue of ₹1.5 Lakh (FY 2024).

DIN 10390276
Primary Designation Director
Industry Paper
First Appointment 10 Nov 2023
Oldest Company Age 2 yrs
Largest company Calian Molecules Private Limited · ₹1.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Calian Molecules Private Limited U21001TS2023PTC178964
Director10 Nov 20232023₹1.5 Lakh (FY 2024)Active

Board colleagues of Maddi Shanthi

Directorship timeline

Open interactive timeline →
Calian Molecules Private Limited
Premium access

Shareholding and investment profile for Maddi Shanthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maddi Shanthi

Maddi Shanthi currently holds 1 directorship: Calian Molecules Private Limited (Director, since 10 Nov 2023, revenue ₹1.5 Lakh (FY 2024)).

Maddi Shanthi was first appointed on 10 Nov 2023 as Director at Calian Molecules Private Limited.

The current boards of Maddi Shanthi's companies include Naresh Amudala (Calian Molecules Private Limited), Swapna Akiti (Calian Molecules Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available